O Scherak

904 total citations
47 papers, 606 citations indexed

About

O Scherak is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, O Scherak has authored 47 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Rheumatology, 9 papers in Immunology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in O Scherak's work include Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). O Scherak is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). O Scherak collaborates with scholars based in Austria, United States and Germany. O Scherak's co-authors include G Kolarz, Wolfgang R. Mayr, N Thumb, W. Graninger, J. S. Smolen, G. Schernthaner, Smolen Js, Josef S Smolen, W. Hassfeld and Klaus Hartmuth and has published in prestigious journals such as Gut, Radiology and CHEST Journal.

In The Last Decade

O Scherak

44 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Scherak Austria 15 363 174 139 92 82 47 606
P. Emery United Kingdom 15 432 1.2× 170 1.0× 108 0.8× 43 0.5× 85 1.0× 60 680
Shinobu Waga Japan 14 118 0.3× 87 0.5× 119 0.9× 131 1.4× 47 0.6× 58 560
Gyula Szegedi Hungary 13 220 0.6× 176 1.0× 34 0.2× 62 0.7× 185 2.3× 46 600
P Hickling United Kingdom 13 440 1.2× 126 0.7× 36 0.3× 50 0.5× 63 0.8× 34 625
H H Chng Singapore 13 363 1.0× 164 0.9× 38 0.3× 45 0.5× 66 0.8× 25 668
Yutaka Furumitsu Japan 11 296 0.8× 130 0.7× 35 0.3× 61 0.7× 59 0.7× 18 596
Ettore Sabadini Italy 13 244 0.7× 139 0.8× 42 0.3× 283 3.1× 74 0.9× 24 747
V. V. Yakusevich Russia 11 164 0.5× 278 1.6× 56 0.4× 53 0.6× 58 0.7× 23 581
Henrique Ataíde Mariz Brazil 11 365 1.0× 247 1.4× 139 1.0× 172 1.9× 147 1.8× 17 695
Tina Mahajan United States 9 288 0.8× 161 0.9× 42 0.3× 107 1.2× 51 0.6× 11 430

Countries citing papers authored by O Scherak

Since Specialization
Citations

This map shows the geographic impact of O Scherak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Scherak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Scherak more than expected).

Fields of papers citing papers by O Scherak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Scherak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Scherak. The network helps show where O Scherak may publish in the future.

Co-authorship network of co-authors of O Scherak

This figure shows the co-authorship network connecting the top 25 collaborators of O Scherak. A scholar is included among the top collaborators of O Scherak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Scherak. O Scherak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scherak, O, Alexander M. Hirschl, H. Nemec, et al.. (2008). Helicobacter pylori und nicht-steroidale Antirheumatika. DMW - Deutsche Medizinische Wochenschrift. 115(31/32). 1171–1175.
2.
Wagner, Ernst, K. Ammer, G Kolarz, et al.. (2007). Predicting factors for severity of rheumatoid arthritis: a prospective multicenter cohort study of 172 patients over 3 years. Rheumatology International. 27(11). 1041–1048. 11 indexed citations
3.
Kolarz, G, Josef Hermann, Ivan Krajnc, et al.. (2002). Funktionelle Kapazität und Cartilage Oligomeric Matrix Protein (COMP) im Serum bei Patienten mit Alterspolyarthritis. Zeitschrift für Rheumatologie. 61(4). 435–439. 3 indexed citations
4.
Pickl, Winfried F., Gottfried Fischer, Ingrid Faé, G Kolarz, & O Scherak. (1993). HLA-DR1-Positive patients suffering from rheumatoid arthritis are at high risk for developing mucocutaneous side effects upon gold therapy. Human Immunology. 38(2). 127–131. 3 indexed citations
5.
Scherak, O, et al.. (1993). Lung Involvement in Rheumatoid Factor-negative Arthritis. Scandinavian Journal of Rheumatology. 22(5). 225–228. 17 indexed citations
6.
Kolarz, G, et al.. (1993). BRONCHOALVEOLAR LAVAGE IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 32(7). 556–561. 24 indexed citations
7.
Popp, Wolfgang, et al.. (1992). Prediction of Interstitial Lung Involvement in Rheumatoid Arthritis. CHEST Journal. 102(2). 391–394. 24 indexed citations
8.
Menzel, J, et al.. (1991). A method to differentiate between anti-C1q antibodies and C1q-binding immune complexes using collagenase-digested solid phase C1q. Journal of Immunological Methods. 138(2). 165–171. 6 indexed citations
9.
Popp, Wolfgang, O Scherak, Otto Braun, et al.. (1990). Bronchoalveolar lavage in rheumatoid arthritis and secondary sjögren’s syndrome. Lung. 168(1). 221–231. 15 indexed citations
10.
Hassfeld, W., G Steiner, Klaus Hartmuth, et al.. (1989). Demonstration of a new antinuclear antibody (ANTI‐RA33) that is highly specific for rheumatoid arthritis. Arthritis & Rheumatism. 32(12). 1515–1520. 83 indexed citations
11.
Smolen, Josef S, John H. Klippel, Edward Penner, et al.. (1987). HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens.. Annals of the Rheumatic Diseases. 46(6). 457–462. 76 indexed citations
12.
Kolarz, G, et al.. (1983). [A non-steroidal antirheumatic agent (nabumetone): effectiveness and tolerance in short and long-term use].. PubMed. 42(2). 82–5. 1 indexed citations
13.
Smolen, J. S., Gerhard Lanzer, O Scherak, et al.. (1981). Concanavalin A-induced suppressor cell activity and in vitro immunoglobulin secretion in rheumatoid arthritis: Correlation with clinical and immunological parameters. Rheumatology International. 1(3). 115–120. 7 indexed citations
14.
Scherak, O, et al.. (1980). Effect of Levamisole on Immunological Parameters in Patients with Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology. 9(2). 106–112. 3 indexed citations
15.
Scherak, O, et al.. (1980). Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4.. PubMed. 7(1). 9–12. 37 indexed citations
16.
Scherak, O, G Kolarz, & W. R. Mayr. (1978). HLA-B8 in caucasian patients with systemic lupus erythematosus. Scandinavian Journal of Rheumatology. 7(1). 3–6. 16 indexed citations
17.
Ludwig, H, G. Schernthaner, O Scherak, & G Kolarz. (1977). Antibodies to pancreatic duct cells in Sjögren's syndrome and rheumatoid arthritis.. Gut. 18(4). 311–315. 32 indexed citations
18.
Kolarz, G, H Ludwig, Mohammad Sabeti, & O Scherak. (1975). [Autoimmune phenomena in D-penicillamine therapy].. PubMed. 2(4). 130–3. 3 indexed citations
19.
Scherak, O & R Höfer. (1975). Szintigraphie mit67Ga-citrat beim Lymphogranulom. DMW - Deutsche Medizinische Wochenschrift. 100(12). 593–596. 1 indexed citations
20.
Fritzsche, H, et al.. (1974). [Clinical possibilities in the use of radioimmunologic TSH determination].. PubMed. 1(1). 17–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Emery Breakdown of academic impact, for papers by Shinobu Waga Breakdown of academic impact, for papers by Gyula Szegedi Breakdown of academic impact, for papers by P Hickling Breakdown of academic impact, for papers by H H Chng Breakdown of academic impact, for papers by Yutaka Furumitsu Breakdown of academic impact, for papers by Ettore Sabadini Breakdown of academic impact, for papers by V. V. Yakusevich Breakdown of academic impact, for papers by Henrique Ataíde Mariz Breakdown of academic impact, for papers by Tina Mahajan
Rankless by CCL
2026